The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies (Q30973716)

27 June 2017

The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies (English)

1 reference

27 June 2017

9

Thomas L Chenevert

1 reference

27 June 2017

Daniel A Hamstra

1

1 reference

27 June 2017

Kuei C Lee

2

1 reference

27 June 2017

Joseph M Tychewicz

3

1 reference

27 June 2017

Victor D Schepkin

4

1 reference

27 June 2017

Bradford A Moffat

5

1 reference

27 June 2017

Mark Chen

6

1 reference

27 June 2017

Kenneth J Dornfeld

7

1 reference

27 June 2017

Theodore S Lawrence

8

1 reference

27 June 2017

Brian D Ross

10

1 reference

27 June 2017

Juri T Gelovani

11

1 reference

27 June 2017

Alnawaz Rehemtulla

12

1 reference

27 June 2017

1 November 2004

1 reference

27 June 2017

1 reference

27 June 2017

10

1 reference

27 June 2017

5

1 reference

27 June 2017

916-928

1 reference

Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives

27 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Combined radiation and enzyme/prodrug treatment for head and neck cancer in an orthotopic animal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Human nerve growth factor receptor and cytosine deaminase fusion genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Concomitant expression of E. coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Characterization of the Saccharomyces cerevisiae FCY1 gene encoding cytosine deaminase and its homologue FCA1 of Candida albicans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

5-fluorouracil metabolism monitored in vivo by 19F NMR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Purification and some properties of uracil phosphoribosyltransferase from Escherichia coli K12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Baker's yeast cytosine deaminase. Enzymic properties and allosteric inhibition by nucleosides and nucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Primary brain tumours in adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Different oligomeric states are involved in the allosteric behavior of uracil phosphoribosyltransferase from Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Recombinant uracil phosphoribosyltransferase from the thermophile Bacillus caldolyticus: expression, purification, and partial characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

The FUR1 gene of Saccharomyces cerevisiae: cloning, structure and expression of wild-type and mutant alleles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat Walker carcinosarcoma following methotrexate pre-treatment: a 19F-MRS study in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Direct detection of intratumoral 5-fluorouracil trapping using metabolic 19F MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Whole-genome random sequencing and assembly of Haemophilus influenzae Rd

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

New colorimetric cytotoxicity assay for anticancer-drug screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.022

10.1016/J.YMTHE.2004.07.022

7 January 2021

Identifiers

DOI

1 reference

27 June 2017

1 reference